Learn / RAPP
NASDAQ: RAPP
Rapport Therapeutics (RAPP) stock, explained like you're 5
Rapport Therapeutics trades on the Nasdaq under the ticker RAPP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
- Ticker
- RAPP
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.5 billion dollars
Is Rapport Therapeutics a small, medium or large cap company?
No. Rapport Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Rapport Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves RAPP stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- UBS Initiates Rapport Therapeutics at Buy With $71 Price Target (Yahoo Finance)
- (RAPP) Movement Within Algorithmic Entry Frameworks (Stock Traders Daily)
- Why is Rapport Therapeutics stock sliding today? (Investing.com)
- Stock replaces Q3 cash retainer as Xos (XOS) director acquires 1,814 shares. (Stock Titan)
- Rapport Therapeutics, Inc. (RAPP) Discusses RAP 219 Phase II Trial and Unmet Needs in Bipolar Mania Slideshow (Seeking Alpha)
Follow RAPP in your daily brief
Each trading day at 5 PM ET we post what happened to Rapport Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow RAPP
Questions about Rapport Therapeutics stock
What does Rapport Therapeutics do?
Rapport Therapeutics trades on the Nasdaq under the ticker RAPP. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
What is the ticker symbol for Rapport Therapeutics?
Rapport Therapeutics trades under the ticker RAPP on the Nasdaq.
What is Rapport Therapeutics's market cap?
Rapport Therapeutics is a small cap stock with a market cap of about 1.5 billion dollars.
How does Rapport Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves RAPP stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow RAPP stock every day?
Add RAPP to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.